(6S,9aS)-N-benzyl-6-[(4-hydroxyphenyl)methyl]-4,7-dioxo-8-({6-[3-(piperazin-1-yl)azetidin-1-yl]pyridin-2-yl}methyl)-2-(prop-2-en-1-yl)-octahydro-1H-pyrazino[2,1-c][1,2,4]triazine-1-carboxamide compound

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9174998
APP PUB NO 20150175615A1
SERIAL NO

14577660

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

A compound represented by formula (1) or pharmaceutically acceptable salt thereof:

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
EISAI R&D MANAGEMENT CO LTDTOKYO 112-8088
PRISM PHARMA CO LTD4259-3 NAGATSUTA-CHO MIDORI-KU YOKOHAMA-SHI KANAGAWA 226-8510

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Inoue, Satoshi Tsukuba, JP 511 10547
Iso, Kentaro Tsukuba, JP 4 27
Yamamoto, Yuji Tsukuba, JP 393 4666

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 May 3, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00